Acceleration of Bcr-Abl+ leukemia induced by deletion of JAK2

Affiliations

• ¹ Department of Biomedical Science, Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria.
• ² 1] Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA [2] Gerstner Sloan-Kettering Graduate School in Biomedical Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
• ³ Department of Biomedical Science, Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna (VUV), Vienna, Austria.
• ⁴ Center for Physiology and Pharmacology, Medical University of Vienna (MUV), Vienna, Austria.
• ⁵ Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁶ Ludwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria.
• ⁷ Eppley Institute for Research in Cancer and Allied Diseases, 985950 Nebraska Medical Center, Omaha, NE, USA.
• ⁸ 1] Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA [2] Department of Medicine, Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.